The Nectero Medical team is excited to attend the VEITH Symposium on November 19-21 in the New York City.?We will be there to connect with our customers and to provide information on our ongoing pivotal trial investigating the ability of the Nectero EAST? System to treat small to mid-sized infrarenal abdominal aortic aneurysms (AAA).?Please visit us at?Booth #211.? #Pharma?#AbdominalAorticAneurysm?#Endovascular?#NecteroMedical #ComboDevice?#Drug?#DrugDelivery?#ClinicalTrials
Nectero Medical, Inc.
生物技术研究
Tempe，Arizona 1,565 位关注者
Transform Lives by Revolutionizing Treatment of Aneurysmal Disease
关于我们
Nectero Medical is a clinical-stage biotech company pioneering novel therapies with a potential to treat aneurysmal disease and improve patients’ lives.
- 网站
-
https://www.necteromedical.com
Nectero Medical, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Tempe，Arizona
- 类型
- 私人持股
- 创立
- 2017
地点
-
主要
获取路线
1155 West Rio Salado Parkway
Suite B-104
US，Arizona，Tempe，85281
Nectero Medical, Inc.员工
动态
-
Dr. Andrew Holden?will?present?an?update on the First-In-Human Study investigating the ability of the Nectero EAST? System to treat small to mid-sized infrarenal abdominal aortic aneurysms (AAA).?The?presentation?will?take place during the?VEITH Symposium on Tuesday, November 19th, at 1:42 PM - 1:47 in?the?Grand Ballroom East, 3rd?Floor.? #Pharma?#AbdominalAorticAneurysm?#Endovascular #NecteroMedical #ComboDevice?#Drug?#DrugDelivery?#ClinicalTrials
-
-
The Nectero Medical team is excited to attend the VEITH Symposium on November 19-21 in the New York City.?We will be there to connect with our customers and to provide information on our ongoing pivotal trial investigating the ability of the Nectero EAST? System to treat small to mid-sized infrarenal abdominal aortic aneurysms (AAA).?Please visit us at?Booth #211.? #Pharma?#AbdominalAorticAneurysm?#Endovascular?#NecteroMedical #ComboDevice?#Drug?#DrugDelivery?#ClinicalTrials
-
NEWS. Nectero Medical recognized as a 2024 AZBio Fast Lane Award Winner. This award is a great?testament to our team’s hard work, dedication and tremendous progress made over the last few years.?#NecteroMedical #Pharma #AbdominalAorticAneurysm #Endovascular #ComboDevice #Drug #DrugDelivery https://lnkd.in/gbxfjZde
-
-
NEWS.?We are excited to welcome?Jack Miceli as the new Chief Financial Officer. Jack brings 25+ years of financial leadership experience to drive strategic growth and maximize shareholder value?#NecteroMedical ?
-
-
BREAKING NEWS.?We are excited to announce completion of the $96M Series D Financing #Pharma?#AbdominalAorticAneurysm?#Endovascular?#NecteroMedical?#ComboDevice?#Drug?#DrugDelivery?#ClinicalTrials
-
-
BREAKING NEWS.?We are excited to announce completion of the $96M Series D Financing #Pharma?#AbdominalAorticAneurysm?#Endovascular?#NecteroMedical?#ComboDevice?#Drug?#DrugDelivery?#ClinicalTrials
-
-
BREAKING NEWS.?We are excited to announce completion of the $96M Series D Financing #Pharma?#AbdominalAorticAneurysm?#Endovascular?#NecteroMedical?#ComboDevice?#Drug?#DrugDelivery?#ClinicalTrials
-
-
We're #hiring a new Regulatory/CMC Project Manager in Tempe, Arizona. Apply today or share this post with your network.
-
We're #hiring a new Clinical Field Specialist in United States. Apply today or share this post with your network.